Mochida Pharmaceutical Co., Ltd.

49
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3922800002
JPY
3,135.00
-5 (-0.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Mochida Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
11,171.00
8,052.00
6,160.00
9,044.00
14,591.00
11,900.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-18,525.00
-1,319.00
-15,140.00
-131.00
-4,317.00
-3,684.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-7,350.00
9,354.00
-7,480.00
7,297.00
7,459.00
9,198.00
Cash Flow from Investing Activities
-16,848.00
17,355.00
74.00
-2,949.00
-2,007.00
-880.00
Cash Flow from Financing Activities
7,033.00
-2,865.00
-6,393.00
-6,884.00
-5,956.00
-5,112.00
Net Cash Inflow / Outflow
-17,092.00
23,860.00
-13,720.00
-2,504.00
-473.00
3,197.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
73.00
16.00
79.00
32.00
31.00
-9.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mochida Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
11171
13165
-1,994.00
-15.15%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-18525
-6559
-11,966.00
-182.44%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-7350
30429
-37,779.00
-124.15%
Cash Flow from Investing Activities
-16848
-25660
8,812.00
34.34%
Cash Flow from Financing Activities
7033
-6828
13,861.00
203.00%
Net Cash Inflow / Outflow
-17092
-649
-16,443.00
-2533.59%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
73
1410
-1,337.00
-94.82%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is -178.58% vs 225.05% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
-7,350.00
9,354.00
-178.58%